TABLE OF CONTENTS INTRODUCTION 2

First Page		Document Content
Date: 2015-06-19 09:17:51 Immunology Immunosuppressants Monoclonal antibodies Autoimmune diseases Biotechnology Infliximab Tumor necrosis factor alpha TNF inhibitor Adalimumab Etanercept Monoclonal antibody therapy Ankylosing spondylitis		TABLE OF CONTENTS INTRODUCTION 2 Add to Reading List Source URL: www.abirisk.eu Download Document from Source Website File Size: 756,10 KB Share Document on Facebook

	BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi DocID: 1rrNB - View Document
	July 15, Bayer Ups Offer to Acquire Monsanto to Approximately $65 Billion Making its first largescale acquisition since becoming a pureplay life sciences company, Bayer has raised its allc DocID: 1qiCw - View Document
	TABLE OF CONTENTS INTRODUCTION 2 DocID: 1qius - View Document
	RHEUMATOLOGY Rheumatology 2011;50:iv5iv9 doi:rheumatology/ker241 Indirect and mixed treatment comparisons in arthritis DocID: 1pLt5 - View Document
	JUNE 2016 TABLE OF CONTENTS INTRODUCTION DocID: 1pshE - View Document